hepatitis c

Hepatitis C virus infection was effectively cured in most patients with the advent of direct-acting antiviral regimens achieving sustained virological response rates above 95%. Despite this therapeutic advance, access barriers mean an estimated 58 million people remain chronically infected globally. Elimination targets set by the WHO require substantial investment in testing, linkage to care, and treatment access, particularly in low- and middle-income countries.